videos
-
.
- eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. .
- .
- a genetic disorder that leads to underdeveloped sweat glands and teeth was treated in the womb .
- .
-
legal
-
.
.
yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital. .